The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant is highly contagious and has been associated with an increasing number of breakthrough infections.
Recent guidelines published by the United States Centers for Disease Control and Prevention (CDC) recommend that healthcare workers who are diagnosed with the coronavirus disease 2019 (COVID-19) can return to work within five days if they are asymptomatic or have only experienced mild to moderate symptoms that are improving. Importantly, infected healthcare workers can return to work even without a negative rapid antigen test (RAT) result.
Study: High Rates of Rapid Antigen Test Positivity After 5 Days of Isolation for COVID-19. Image Credit: Michele Ursi / Shutterstock.com
A new study published on the preprint server medRxiv* shows that a high proportion of individuals still tested positive for SARS-CoV-2 infection using RATs after five days of quarantine.
SARS-CoV-2 dynamics and RAT
After SARS-CoV-2 infection, viral shedding begins two to three days before the onset of symptoms. Viral shedding correlates with infectiousness or contagiousness.
Maximal virus shedding is often observed one day before the onset of symptoms. On average, infectiousness continues through day three of illness.
RATs are highly sensitive assays that detect the presence of SARS-CoV-2 in nasal swabs, particularly when concomitant reverse-transcriptase polymerase chain reaction (RT-PCR) tests are also positive. Furthermore, several studies have shown that darker or more intense positive results with RAT indicate higher viral counts.
About the study
The current study assessed healthcare workers from a large, urban, academic medical center. All participants were fully vaccinated and non-immunocompromised.
Individuals who tested positive for SARS-CoV-2 starting in late December 2021 were selected for the study, which is when the Omicron variant was widely circulating. All infected healthcare workers were allowed to return to work early if all symptoms had resolved except for mild, intermittent cough and/or lingering loss of taste/smell. Importantly, a negative RAT was required before the healthcare worker was allowed to return to work.
Quidell Quickview (San Diego, CA, USA) point of care RAT was performed on qualifying healthcare workers as soon as day five of their illness. Day 1 of illness was the start of symptoms or test date if asymptomatic.
RAT positive results were recorded as 1 for a positive result line in which the intensity was darker than the control line, 2 for the intensity that was the same as the control line, or 3 for intensity lighter than the control line.
A total of 260 healthcare workers were tested between days five and ten of their illness between January 2, 2022, and January 12, 2022. Taken together, 309 tests were performed.
Among the 260 individuals, 43% were RAT positive between days five and ten. On day six, 58% of individuals tested RAT positive, which was the highest rate of positivity reported in this study. Only 26% of individuals tested RAT positive on days eight and nine.
Among the RAT-positive individuals who tested after their first test on days five or six, 49% had the darkest intensity on their RAT. Individuals who tested positive on their first test mostly tested positive on their second test as well, with 56% of positive second tests aggregated across days 6-10. Among the healthcare workers, 53% of boosted individuals tested positive.
More than 40% of fully vaccinated healthcare workers who were well enough to resume work still had positive RAT tests between days five and ten. Boosted individuals were nearly three times as likely to test positive on day five and around twice as likely to test positive on their first RAT overall.
Participation in this study was voluntary; therefore, all healthcare workers did not report every day for testing. Many non-medical factors may have influenced the timing of the RAT.
Since RAT test results correlate with the presence of cultivable viruses, it is believed that healthcare workers with positive RAT are likely still contagious; however, this correlation has not been established for the Omicron variant. Thus, the current study is being continued to establish this corroboration.
The SARS-CoV-2 dynamics of the Omicron variant are different from previous variants. The trend observed between the onset of symptoms and peak virus load has changed.
In light of this data, five days from symptom onset may no longer be an appropriate window to end isolation. Instead, a negative RAT should support a safe exit from isolation.
The current study demonstrates that a substantial proportion of individuals with COVID-19 are assumably still contagious after day five of illness. This is independent of the status of symptoms.
If individuals return to their communities or work settings between days six and ten of illness, it may increase the spread of SARS-CoV-2 to others. As a result, more workers will likely get infected with SARS-CoV-2, thereby undermining the intended benefits of a shortened quarantine period to staffing issues.
medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.
- Landon, E. M., Bartlett, A. H., Marrs, R., et al. (2022) High Rates of Rapid Antigen Test Positivity After 5 Days of Isolation for COVID-19. medRxiv. doi:10.1101/2022.02.01.22269931. https://www.medrxiv.org/content/10.1101/2022.02.01.22269931v1.
Posted in: Men's Health News | Medical Research News | Medical Condition News | Women's Health News | Disease/Infection News
Tags: Antigen, Coronavirus, Coronavirus Disease COVID-19, Cough, Diagnostics, Healthcare, Omicron, Polymerase, Polymerase Chain Reaction, Respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Syndrome, Virus
Dr. Shital Sarah Ahaley
Dr. Shital Sarah Ahaley is a medical writer. She completed her Bachelor's and Master's degree in Microbiology at the University of Pune. She then completed her Ph.D. at the Indian Institute of Science, Bengaluru where she studied muscle development and muscle diseases. After her Ph.D., she worked at the Indian Institute of Science, Education, and Research, Pune as a post-doctoral fellow. She then acquired and executed an independent grant from the DBT-Wellcome Trust India Alliance as an Early Career Fellow. Her work focused on RNA binding proteins and Hedgehog signaling.
Source: Read Full Article